BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30516690)

  • 21. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT.
    Alabed YZ
    Clin Nucl Med; 2018 Mar; 43(3):220-221. PubMed ID: 29356739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
    Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
    J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
    How Kit N; Dugué AE; Sevin E; Allouache N; Lesaunier F; Joly F; Aide N
    Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    Nanni C; Zanoni L; Pultrone C; Schiavina R; Brunocilla E; Lodi F; Malizia C; Ferrari M; Rigatti P; Fonti C; Martorana G; Fanti S
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1601-10. PubMed ID: 26960562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidental Papillary Bladder Carcinoma on 18F-Fluoromethylcholine PET/CT Undertaken to Evaluate Prostate Malignancy.
    Parekh A; Hagan I; Capaldi L; Lyburn I
    Clin Nucl Med; 2017 Sep; 42(9):721-722. PubMed ID: 28682845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse.
    Maffione AM; Mandoliti G; Pasini F; Colletti PM; Rubello D
    Clin Nucl Med; 2016 Oct; 41(10):e460-1. PubMed ID: 27500509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squamous cell carcinoma of the tonsil incidentally detected by 18F-choline PET/CT.
    Treglia G; Ceriani L; Barizzi J; Bertagna F; Giovanella L
    Clin Nucl Med; 2015 Jan; 40(1):93-5. PubMed ID: 24662666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic Metastases From Prostatic Adenocarcinoma Without Elevated 18F-Choline Activity.
    Dejust S; Messaoud L; Jallerat P; Marical V; Morland D
    Clin Nucl Med; 2018 Oct; 43(10):780-781. PubMed ID: 30153155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidental detection of Hürthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer.
    Paone G; Treglia G; Bongiovanni M; Ruberto T; Ceriani L; Giovanella L
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):340-1. PubMed ID: 23796426
    [No Abstract]   [Full Text] [Related]  

  • 32. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asymptomatic metastasis to cricoid from prostate carcinoma: an incidental finding detected on 18F-choline PET/CT.
    Ng SJ; Sinha AK; Loi HY; Khor LK
    Jpn J Radiol; 2015 May; 33(5):298-301. PubMed ID: 25820451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.
    De Leiris N; Riou L; Leenhardt J; Vuillez JP; Djaileb L
    Clin Nucl Med; 2018 Dec; 43(12):e471-e472. PubMed ID: 30300202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.
    Rensi M; Ferretti G; Di Gregorio F; Evangelista L
    Clin Nucl Med; 2019 Feb; 44(2):e116-e117. PubMed ID: 30516662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between local recurrences and distant metastases in prostate cancer: can
    Giovacchini G; Ciarmiello A; Giovannini E; Fodor A; Cozzarini C; Mapelli P; Incerti E; Di Muzio N; Gianolli L; Picchio M
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):962-969. PubMed ID: 29453702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected diagnosis of peripheral schwannoma on 18F-fluoroethylcholine PET/CT for localization of prostate cancer recurrence and biopsy under real-time PET/ultrasound fusion guidance.
    Freesmeyer M; Drescher R; Winkens T
    Clin Nucl Med; 2014 Apr; 39(4):385-6. PubMed ID: 24561678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of
    Jiménez Londoño GA; García Vicente AM; Amo-Salas M; Fúnez Mayorga F; López Guerrero MA; Talavera Rubio MP; Gutierrez Martin P; González García B; de la Torre Pérez JA; Soriano Castrejón ÁM
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):241-246. PubMed ID: 28330596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
    Häcker A; Jeschke S; Leeb K; Prammer K; Ziegerhofer J; Sega W; Langsteger W; Janetschek G
    J Urol; 2006 Nov; 176(5):2014-8; discussion 2018-9. PubMed ID: 17070241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.